Exploring the alteration of gut microbiota and brain function in gender-specific Parkinson's disease based on metagenomic sequencingOriginal paper
Karen Pendergrass is a microbiome researcher specializing in microbiome-targeted interventions (MBTIs). She systematically analyzes scientific literature to identify microbial patterns, develop hypotheses, and validate interventions. As the founder of the Microbiome Signatures Database, she bridges microbiome research with clinical practice. In 2012, based on her own investigative research, she became the first documented case of FMT for Celiac Disease, four years before the first published case study.
Read MoreWhat was studied?
Researchers examined whether gut microbiota differ by sex in Parkinson's disease and whether these differences relate to brain function. They analyzed fresh fecal samples from 24 Parkinson's patients, 13 male and 11 female.
How was it studied?
Fecal samples underwent metagenomic sequencing to characterize microbiota composition and function. Resting-state functional MRI measured brain activity via ALFF values, and the two datasets were correlated by sex.
What did they find?
Propionivibrio, Thermosediminibacter, and Flavobacteriaceae were increased in male patients, with Akkermansiaceae and Akkermansia also dominant by LEfse analysis. In female patients, Propionicicella was decreased while Escherichia, Escherichia coli, and Lachnospiraceae predominated. Sesquiterpenoid and triterpenoid biosynthesis pathways were elevated in males versus females. Females showed reduced ALFF values in the left inferior parietal region compared to males, and Propionivibrio abundance correlated positively with regional ALFF (r equals 0.45, p equals 0.027).
Why it matters
This is described as the first clinical evidence linking sex-specific gut microbiota alterations to brain function differences in Parkinson's disease. It supports a role for the microbiota-gut-brain axis in explaining known sex differences in PD epidemiology and course.